New treatment helps achieve a healthier BMI in people with weight dysregulation after brain tumors

Дата публикации: 09-07-2026 16:00:09

A new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found. The results of the trial have been published in the New England Journal of Medicine. The new drug, setmelanotide, offers hope for improved health and quality of life for children and adults with hormonal and metabolic dysfunction caused by a brain tumor.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Weight‑loss jabs may create a new kind of yo‑yo dieting	0	7	10-07-2026
2	Найден способ вылечить редкую форму ожирения	7	8	09-07-2026
3	New vitamin B12 therapy shows promise against deadly brain cancer	0	10.4	27-06-2026
4	Ученые нашли природный пептид, способный заменить «Оземпик» — без побочных эффектов	0	6.81	27-07-2026
5	7 things to know about Medicare's new GLP-1 coverage	0	7	02-07-2026
6	Weight-loss jab users more likely to report changes in taste and smell, study finds	0	7	29-06-2026
7	Biomarker discovery could advance treatments for obesity-related health risks	0	10.93	24-07-2026
8	Bofanglutide linked to meaningful reductions in HbA1c in adults with T2DM	5	7	02-07-2026
9	GLP-1 use hits record high as Medicare opens access to weight-loss drugs	0	7	09-07-2026
10	Societies combine to issue recommendations on use of incretin drugs in obesity therapy	0	7	09-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: medicalxpress.com.